Mirae Asset Global ETFs Holdings
CRMD icon

Mirae Asset Global ETFs Holdings’s CorMedix CRMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
34,344
-1,336
-4% -$10.6K ﹤0.01% 2338
2026
Q1 		$242K Buy
35,680
+1,215
+4% +$8.98K ﹤0.01% 2254
2025
Q4 		$401K Buy
34,465
+1,739
+5% +$19.2K ﹤0.01% 1994
2025
Q3 		$381K Buy
+32,726
New +$396K ﹤0.01% 2002
2025
Q2 		– Sell
-35,987
Closed -$222K – 3054
2025
Q1 		$222K Buy
35,987
+1,631
+5% +$16.9K ﹤0.01% 2271
2024
Q4 		$278K Buy
34,356
+4,295
+14% +$42.9K ﹤0.01% 2217
2024
Q3 		$243K Buy
30,061
+2,402
+9% +$13K ﹤0.01% 2279
2024
Q2 		$120K Buy
+27,659
New +$141K ﹤0.01% 2491

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CRMD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its CorMedix (CRMD) stake by 3.7% in Q2 2026, selling an estimated $10.6K and leaving 34,344 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Mirae Asset Global ETFs Holdings first reported a position in CRMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $401K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 34,344 shares of CorMedix worth $270K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,336 CorMedix shares in Q2 2026, an estimated $10.6K.
  • CorMedix made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2338 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in CorMedix in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's CorMedix position peaked at $401K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.